Diabetes, Vol 48, Issue 3 640-642, Copyright © 1999 by American Diabetes Association

ARTICLES

Exclusion of insulin receptor substrate 2 (IRS-2) as a major locus for early-onset autosomal dominant type 2 diabetes

A Bektas, JH Warram, MF White, AS Krolewski and A Doria
Joslin Diabetes Center, and the Department of Medicine, Harvard Medical School, Boston, Massachusetts 02215, USA.

We investigated whether variability at the insulin receptor substrate (IRS)-2 locus plays a role in the etiology of early-onset autosomal dominant type 2 diabetes. By means of radiation hybrid mapping, we placed the human IRS-2 gene on 13q at 8.6 cRays from SHGC-37358. Linkage between diabetes and two polymorphic markers located in this region (D13S285 and D13S1295) was then evaluated in 29 families with early-onset autosomal dominant type 2 diabetes. Included were 220 individuals with diabetes, impaired glucose tolerance, or gestational diabetes (mean age at diabetes diagnosis 36 +/- 17 years) and 146 nondiabetic subjects. Overall, strongly negative logarithm of odds (LOD) scores for linkage with diabetes were obtained by multipoint parametric analysis (LOD score -45.4 at D13S285 and -40.9 at D13S1295). No significant evidence of linkage was obtained under the hypothesis of heterogeneity or by nonparametric methods. Fourteen pedigrees for which linkage could not be excluded (LOD score > -2.0) were screened for mutations in the IRS-2 coding region by dideoxy fingerprinting. However, no mutations segregating with diabetes could be detected in these families. These data indicate that IRS-2 is not a major gene for early-onset autosomal dominant type 2 diabetes, although a role of mutations in the promoter region cannot be excluded at this time.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				G. Cai, S. A. Cole, J. H. Freeland-Graves, J. W. MacCluer, J. Blangero, and A. G. Comuzzie Genome-Wide Scans Reveal Quantitative Trait Loci on 8p and 13q Related to Insulin Action and Glucose Metabolism: The San Antonio Family Heart Study Diabetes, May 1, 2004; 53(5): 1369 - 1374. [Abstract] [Full Text] [PDF]

				A. NANDI, Y. KITAMURA, C. R. KAHN, and D. ACCILI Mouse Models of Insulin Resistance Physiol Rev, April 1, 2004; 84(2): 623 - 647. [Abstract] [Full Text] [PDF]

				M. Schubert, D. P. Brazil, D. J. Burks, J. A. Kushner, J. Ye, C. L. Flint, J. Farhang-Fallah, P. Dikkes, X. M. Warot, C. Rio, et al. Insulin Receptor Substrate-2 Deficiency Impairs Brain Growth and Promotes Tau Phosphorylation J. Neurosci., August 6, 2003; 23(18): 7084 - 7092. [Abstract] [Full Text] [PDF]

				R. D'Alfonso, M. A. Marini, L. Frittitta, R. Sorge, S. Frontoni, O. Porzio, L. M. Mariani, D. Lauro, S. Gambardella, V. Trischitta, et al. Polymorphisms of the Insulin Receptor Subtrate-2 in Patients with Type 2 Diabetes J. Clin. Endocrinol. Metab., January 1, 2003; 88(1): 317 - 322. [Abstract] [Full Text] [PDF]

				C. Menzaghi, N. Plengvidhya, X. Ma, J. H. Warram, S. E. Shoelson, and A. Doria COMMENT: Genetic Variability in Insulin Action Inhibitor Ikk{beta} (IKBKB) Does Not Play a Major Role in the Development of Type 2 Diabetes J. Clin. Endocrinol. Metab., April 1, 2002; 87(4): 1894 - 1897. [Abstract] [Full Text] [PDF]

				A. Fritsche, A. Madaus, W. Renn, O. Tschritter, A. Teigeler, M. Weisser, E. Maerker, F. Machicao, H. Haring, and M. Stumvoll The Prevalent Gly1057Asp Polymorphism in the Insulin Receptor Substrate-2 Gene Is Not Associated with Impaired Insulin Secretion J. Clin. Endocrinol. Metab., October 1, 2001; 86(10): 4822 - 4825. [Abstract] [Full Text] [PDF]

				G. SESTI, M. FEDERICI, M. L. HRIBAL, D. LAURO, P. SBRACCIA, and R. LAURO Defects of the insulin receptor substrate (IRS) system in human metabolic disorders FASEB J, October 1, 2001; 15(12): 2099 - 2111. [Abstract] [Full Text] [PDF]

				S. A. El Mkadem, C. Lautier, F. Macari, N. Molinari, P. Lefebvre, E. Renard, J. C. Gris, G. Cros, J. P. Daures, J. Bringer, et al. Role of Allelic Variants Gly972Arg of IRS-1 and Gly1057Asp of IRS-2 in Moderate-to-Severe Insulin Resistance of Women With Polycystic Ovary Syndrome Diabetes, September 1, 2001; 50(9): 2164 - 2168. [Abstract] [Full Text] [PDF]

				Y. Kido, J. Nakae, and D. Accili The Insulin Receptor and Its Cellular Targets J. Clin. Endocrinol. Metab., March 1, 2001; 86(3): 972 - 979. [Abstract] [Full Text]

				A. Parker, J. Meyer, S. Lewitzky, J. S. Rennich, G. Chan, J. D. Thomas, M. Orho-Melander, M. Lehtovirta, C. Forsblom, A. Hyrkkö, et al. A Gene Conferring Susceptibility to Type 2 Diabetes in Conjunction With Obesity Is Located on Chromosome 18p11 Diabetes, March 1, 2001; 50(3): 675 - 680. [Abstract] [Full Text]

				S. P. Cousin, S. R. Hugl, C. E. Wrede, H. Kajio, M. G. Myers Jr., and C. J. Rhodes Free Fatty Acid-Induced Inhibition of Glucose and Insulin-Like Growth Factor I-Induced Deoxyribonucleic Acid Synthesis in the Pancreatic {beta}-Cell Line INS-1 Endocrinology, January 1, 2001; 142(1): 229 - 240. [Abstract] [Full Text] [PDF]

				S. Matthaei, M. Stumvoll, M. Kellerer, and H.-U. Häring Pathophysiology and Pharmacological Treatment of Insulin Resistance Endocr. Rev., December 1, 2000; 21(6): 585 - 618. [Abstract] [Full Text]

				M. L. Hribal, M. Federici, O. Porzio, D. Lauro, P. Borboni, D. Accili, R. Lauro, and G. Sesti The Gly->Arg972 Amino Acid Polymorphism in Insulin Receptor Substrate-1 Affects Glucose Metabolism in Skeletal Muscle Cells J. Clin. Endocrinol. Metab., May 1, 2000; 85(5): 2004 - 2013. [Abstract] [Full Text]